Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
27.67
-0.09 (-0.32%)
At close: Feb 13, 2026

SHA:688393 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,5891,6202,3362,0532,8443,452
Market Cap Growth
57.93%-30.68%13.78%-27.80%-17.60%-
Enterprise Value
2,3121,4982,2071,7342,0812,623
Last Close Price
27.6717.2524.6621.6029.5435.60
PE Ratio
-76.0758.3348.1035.6540.73
PS Ratio
6.983.444.704.056.489.19
PB Ratio
2.161.321.891.682.352.96
P/TBV Ratio
2.181.321.901.722.432.99
P/FCF Ratio
115.51----119.12
P/OCF Ratio
67.21457.11136.46211.3447.7137.75
EV/Sales Ratio
6.233.184.443.424.746.99
EV/EBITDA Ratio
-44.4848.2532.2227.6329.69
EV/EBIT Ratio
--292.6380.7235.4033.68
EV/FCF Ratio
103.15----90.53
Debt / Equity Ratio
0.010.010.020.020.01-
Debt / EBITDA Ratio
5.870.300.580.430.16-
Net Debt / Equity Ratio
-0.21-0.11-0.07-0.20-0.52-0.72
Net Debt / EBITDA Ratio
-256.95-4.16-2.01-4.49-8.29-9.57
Net Debt / FCF Ratio
-11.156.974.453.877.46-29.18
Asset Turnover
0.280.340.360.370.330.41
Inventory Turnover
1.562.002.352.883.013.34
Quick Ratio
6.394.713.354.467.9911.82
Current Ratio
9.058.195.145.218.5112.16
Return on Equity (ROE)
-1.64%1.21%1.71%2.41%6.33%10.37%
Return on Assets (ROA)
-1.73%-0.21%0.34%0.97%2.77%5.32%
Return on Invested Capital (ROIC)
-3.72%-0.41%0.71%2.74%10.85%21.89%
Return on Capital Employed (ROCE)
-3.00%-0.40%0.60%1.70%4.70%6.50%
Earnings Yield
-0.74%1.31%1.71%2.08%2.80%2.46%
FCF Yield
0.87%-1.24%-0.88%-3.04%-2.94%0.84%
Dividend Yield
0.36%0.58%0.61%0.65%0.91%0.79%
Payout Ratio
-68.14%33.62%62.34%33.00%-
Buyback Yield / Dilution
6.37%2.94%-0.53%-1.09%-20.71%-11.39%
Total Shareholder Return
6.73%3.52%0.08%-0.44%-19.80%-10.60%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.